The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
Open accessAbstract
The HVEM (TNFRSF14) receptor gene is among the most frequently mutated genes in germinal center lymphomas. We report that loss of HVEM leads to cell autonomous activation of B cell proliferation and drives the development of GC lymphomas in vivo. HVEM deficient lymphoma B cells also induce a tumor supportive microenvironment marked by exacerbated lymphoid stroma activation and increased recruitment of T follicular helper (TFH) cells. These changes result from the disruption of inhibitory cell-cell interactions between the HVEM and BTLA (B and T Lymphocyte Attenuator) receptors. Accordingly, administration of the HVEM ectodomain protein (solHVEM(P37-V202)) binds BTLA and restores tumor suppression. To deliver solHVEM to lymphomas in vivo we engineered CD19-targeted chimeric antigen receptor (CAR) T cells that produce solHVEM locally and continuously. These modified CAR-T cells show enhanced therapeutic activity against xenografted lymphomas. Hence, the HVEM-BTLA axis opposes lymphoma development and our study illustrates the use of CAR-T cells as ‘micro-pharmacies’ able to deliver an anti-cancer protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Circular binary segmentation for the analysis of array-based DNA copy number data
Olshen, A. B., Venkatraman, E. S., Lucito, R., & Wigler, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh008 · Cited by 2,325
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
Self-citationT follicular helper cell differentiation, function, and roles in disease
Crotty, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.004 · Cited by 1,847
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Self-citationFrequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Self-citationDave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D., Chan, W. C., Fisher, R. I., Braziel, R. M., Rimsza, L. M., Grogan, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041869 · Cited by 1,418
Self-citationGuidelines for the Design and Statistical Analysis of Experiments Using Laboratory Animals
Festing, M. F. W., & Altman, D. G. (2002) · ILAR Journal · doi:10.1093/ilar.43.4.244 · Cited by 1,110
Dynamics of B cells in germinal centres
De Silva, N. S., & Klein, U. (2015) · Nature Reviews Immunology · doi:10.1038/nri3804 · Cited by 1,084
Lohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121343109 · Cited by 974
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Self-citationBTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883
Okosun, J., Bödör, C., Wang, J., Araf, S., Yang, C.-Y., Pan, C., Boller, S., Cittaro, D., Bozek, M., Iqbal, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2856 · Cited by 734
Pegram, H. J., Lee, J. C., Hayman, E. G., Imperato, G. H., Tedder, T. F., Sadelain, M., & Brentjens, R. J. (2012) · Blood · doi:10.1182/blood-2011-12-400044 · Cited by 678
Self-citationBrentjens, R. J., Latouche, J.-B., Santos, E., Marti, F., Gong, M. C., Lyddane, C., King, P. D., Larson, S., Weiss, M., Rivière, I., et al. (2003) · Nature Medicine · doi:10.1038/nm827 · Cited by 669
Self-citationGenetics of Follicular Lymphoma Transformation
Pasqualucci, L., Khiabanian, H., Fangazio, M., Vasishtha, M., Messina, M., Holmes, A. B., Ouillette, P., Trifonov, V., Rossi, D., Tabbò, F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.027 · Cited by 573
Self-citationStromal cell contributions to the homeostasis and functionality of the immune system
Mueller, S. N., & Germain, R. N. (2009) · Nature Reviews Immunology · doi:10.1038/nri2588 · Cited by 524
Challa-Malladi, M., Lieu, Y. K., Califano, O., Holmes, A. B., Bhagat, G., Murty, V. V., Dominguez-Sola, D., Pasqualucci, L., & Dalla-Favera, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.006 · Cited by 439
Ortega-Molina, A., Boss, I. W., Canela, A., Pan, H., Jiang, Y., Zhao, C., Jiang, M., Hu, D., Agirre, X., Niesvizky, I., et al. (2015) · Nature Medicine · doi:10.1038/nm.3943 · Cited by 436
Self-citationLymph node fibroblastic reticular cells in health and disease
Fletcher, A. L., Acton, S. E., & Knoblich, K. (2015) · Nature Reviews Immunology · doi:10.1038/nri3846 · Cited by 340
Balancing co-stimulation and inhibition with BTLA and HVEM
Murphy, K. M., Nelson, C. A., & Šedý, J. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1917 · Cited by 309
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation
Cai, G., & Freeman, G. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00783.x · Cited by 301
Novel immunotherapies in lymphoid malignancies
Batlevi, C. L., Matsuki, E., Brentjens, R. J., & Younes, A. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.187 · Cited by 260
Self-citationThe signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
Steinberg, M. W., Cheung, T. C., & Ware, C. F. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01064.x · Cited by 243
Amé-Thomas, P., Maby-El Hajjami, H., Monvoisin, C., Jean, R., Monnier, D., Caulet-Maugendre, S., Guillaudeux, T., Lamy, T., Fest, T., & Tarte, K. (2007) · Blood · doi:10.1182/blood-2006-05-020800 · Cited by 240
Self-citationLi, S., Lefranc, M.-P., Miles, J. J., Alamyar, E., Giudicelli, V., Duroux, P., Freeman, J. D., Corbin, V. D. A., Scheerlinck, J.-P., Frohman, M. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3333 · Cited by 222
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia
Egle, A., Harris, A. W., Bath, M. L., O'Reilly, L., & Cory, S. (2004) · Blood · doi:10.1182/blood-2003-07-2469 · Cited by 221
Cheung, T. C., Humphreys, I. R., Potter, K. G., Norris, P. S., Shumway, H. M., Tran, B. R., Patterson, G., Jean-Jacques, R., Yoon, M., Spear, P. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506172102 · Cited by 209
Stromal Cell–Immune Cell Interactions
Roozendaal, R., & Mebius, R. E. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101357 · Cited by 204
Gavrieli, M., Watanabe, N., Loftin, S. K., Murphy, T. L., & Murphy, K. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.070 · Cited by 190
Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
Cheung, K.-J. J., Johnson, N. A., Affleck, J. G., Severson, T., Steidl, C., Ben-Neriah, S., Schein, J., Morin, R. D., Moore, R., Shah, S. P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2460 · Cited by 186
Self-citationLi, H., Kaminski, M. S., Li, Y., Yildiz, M., Ouillette, P., Jones, S., Fox, H., Jacobi, K., Saiya-Cork, K., Bixby, D., et al. (2014) · Blood · doi:10.1182/blood-2013-05-500264 · Cited by 181
Self-citationAmé-Thomas, P., Le Priol, J., Yssel, H., Caron, G., Pangault, C., Jean, R., Martin, N., Marafioti, T., Gaulard, P., Lamy, T., et al. (2012) · Leukemia · doi:10.1038/leu.2011.301 · Cited by 177
Self-citationFollicular dendritic cells: origin, phenotype, and function in health and disease
Aguzzi, A., Kranich, J., & Krautler, N. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.11.001 · Cited by 176
The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma
Oricchio, E., Nanjangud, G., Wolfe, A. L., Schatz, J. H., Mavrakis, K. J., Jiang, M., Liu, X., Bruno, J., Heguy, A., Olshen, A. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.035 · Cited by 172
Self-citationStromal infrastructure of the lymph node and coordination of immunity
Chang, J. E., & Turley, S. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.11.003 · Cited by 164
Guilloton, F., Caron, G., Ménard, C., Pangault, C., Amé-Thomas, P., Dulong, J., De Vos, J., Rossille, D., Henry, C., Lamy, T., et al. (2012) · Blood · doi:10.1182/blood-2011-08-370908 · Cited by 159
Self-citationActivating STAT6 mutations in follicular lymphoma
Yildiz, M., Li, H., Bernard, D., Amin, N. A., Ouillette, P. D., Jones, S., Saiya-Cork, K., Parkin, B. L., Jacobi, K., Shedden, K., et al. (2014) · Blood · doi:10.1182/blood-2014-06-582650 · Cited by 158
Self-citationHVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation
del Rio, M., Lucas, C. L., Bühler, L. H., Rayat, G. R., & Rodríguez-Barbosa, J.-I. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809590 · Cited by 157
Cheung, T. C., Oborne, L. M., Steinberg, M. W., Macauley, M. G., Fukuyama, S., Sanjo, H., D'Souza, C., Norris, P. S., Pfeffer, K., MURPHY, K. M. M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902490 · Cited by 156
Amin, R., Mourcin, F., Uhel, F., Pangault, C., Ruminy, P., Dupré, L., Guirriec, M., Marchand, T., Fest, T., Lamy, T., et al. (2015) · Blood · doi:10.1182/blood-2015-04-640912 · Cited by 148
Self-citationFollicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis
Pangault, C., Amé-Thomas, P., Ruminy, P., Delphine Rossille, A., Caron, G., Baia, M., Vos, J. D., Roussel, M., Monvoisin, C., Lamy, T., et al. (2010) · Leukemia · doi:10.1038/leu.2010.223 · Cited by 142
Self-citationBouska, A. C., McKeithan, T. W., Deffenbacher, K. E., Lachel, C. M., Wright, G. W., Iqbal, J., Smith, L. M., Zhang, W., Küçük, C., Rinaldi, A., et al. (2013) · Blood · doi:10.1182/blood-2013-05-500595 · Cited by 139
Self-citationB and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK
Vendel, A. C., Calemine-Fenaux, J., Izrael-Tomasevic, A., Chauhan, V., Arnott, D. P., & Eaton, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1509 · Cited by 120
Schatz, J. H., Oricchio, E., Wolfe, A. L., Jiang, M., Linkov, I., Maragulia, J., Shi, W., Zhang, Z., Rajasekhar, V. K., Pagano, N. C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110846 · Cited by 119
Self-citationLaunay, E., Pangault, C., Bertrand, P., Jardin, F., Lamy, T., Tilly, H., Tarte, K., Bastard, C., & Fest, T. (2011) · Leukemia · doi:10.1038/leu.2011.266 · Cited by 116
Self-citationTumorigenic activity and therapeutic inhibition of Rheb GTPasePreprint
Mavrakis, K. J., Zhu, H., Silva, R. L. A., Mills, J. R., Teruya‐Feldstein, J., Lowe, S. W., Tam, W., Pelletier, J., & Wendel, H. (2008) · Genes & Development · doi:10.1101/gad.1690808 · Cited by 113
Self-citationRoss, C. W., Ouillette, P. D., Saddler, C. M., Shedden, K., & Malek, S. N. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0456 · Cited by 108
Self-citationAmé-Thomas, P., & Tarte, K. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.001 · Cited by 106
Self-citationM’Hidi, H., Thibult, M., Chetaille, B., Gondois‐Rey, F., Bouadallah, R., Nicollas, R., Olive, D., & Xerri, L. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpphkgyyggl39c · Cited by 93
Rehm, A., Mensen, A., Schradi, K., Gerlach, K., Wittstock, S., Winter, S., Büchner, G., Dörken, B., Lipp, M., & Höpken, U. E. (2011) · Blood · doi:10.1182/blood-2010-11-321265 · Cited by 77
Pasero, C., Speiser, D. E., Derré, L., & Olive, D. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.03.001 · Cited by 77
Martín‐Guerrero, I., Salaverría, I., Burkhardt, B., Szczepanowski, M., Baudis, M., Bens, S., de Leval, L., García‐Orad, Á., Horn, H., Lisfeld, J., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.073916 · Cited by 72
Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis
Mourcin, F., Pangault, C., Amin-Ali, R., Amé-Thomas, P., & Tarte, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00280 · Cited by 67
Self-citationCD19 CAR Therapy for Acute Lymphoblastic Leukemia
Sadelain, M., Brentjens, R. J., Rivière, I., & Park, J. H. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e360 · Cited by 51
Self-citationCostello, R. T., Mallet, F., Barbarat, B., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403175 · Cited by 41
Oricchio, E., Ciriello, G., Jiang, M., Boice, M., Schatz, J. H., Heguy, A., Viale, A. J., de Stanchina, E., Teruya‐Feldstein, J., Bouska, A. C., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132120 · Cited by 39
Self-citationLauenborg, B. T., Christensen, L. D., Ralfkiær, U., Kopp, K., Jønson, L., Dabelsteen, S., Bonefeld, C. M., Geisler, C., Gjerdrum, L. M. R., Zhang, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3837 · Cited by 34
Lymphotoxin network pathways shape the tumor microenvironment
Bjordahl, R., Steidl, C., Gascoyne, R. D., & Ware, C. F. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.01.001 · Cited by 33
Self-citation
Cited by
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0016-8 · Cited by 1,941
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
CAR immune cells: design principles, resistance and the next generation
Labanieh, L., & Mackall, C. L. (2023) · Nature · doi:10.1038/s41586-023-05707-3 · Cited by 658
Genetics of diffuse large B-cell lymphoma
Pasqualucci, L., & Dalla-Favera, R. (2018) · Blood · doi:10.1182/blood-2017-11-764332 · Cited by 282
Challenges and new technologies in adoptive cell therapy
Zhang, P., Zhang, G., & Wan, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01492-8 · Cited by 259
Metadata
- Authors
- Boice, M., Salloum, D., Mourcin, F., Sanghvi, V., Amin, R., Oricchio, E., Jiang, M., Mottok, A., Denis-Lagache, N., Ciriello, G., Tam, W., Teruya-Feldstein, J., de Stanchina, E., Chan, W. C., Malek, S. N., Ennishi, D., Brentjens, R. J., Gascoyne, R. D., Cogné, M., Tarte, K., & Wendel, H.-G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 167
- Issue
- 2
- Pages
- 405-418.e13
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2524917460
- Cited by
- 257
- References
- 59
- FWCI
- 13.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
